Bill Few Associates’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
2,579
-247
-9% -$75K 0.24% 85
2026
Q1
$604K Sell
2,826
-83
-3% -$18.6K 0.14% 109
2025
Q4
$498K Hold
2,909
0.12% 117
2025
Q3
$390K Hold
2,909
0.1% 132
2025
Q2
$283K Buy
2,909
+9
+0.3% +$714 0.08% 153
2025
Q1
$211K Hold
2,900
0.08% 170
2024
Q4
$209K Buy
+2,900
New +$220K 0.07% 163
2024
Q3
Sell
-3,100
Closed -$330K 181
2024
Q2
$330K Sell
3,100
-470
-13% -$45.1K 0.13% 126
2024
Q1
$347K Hold
3,570
0.14% 115
2023
Q4
$280K Buy
+3,570
New +$243K 0.13% 125

Other funds holding LRCX

Bill Few Associates's LRCX Position: Q2 2026 in Review

Bill Few Associates reduced its Lam Research (LRCX) stake by 8.7% in Q2 2026, selling an estimated $75K and leaving 2,579 shares worth $1.12M. The position accounts for 0.24% of the portfolio, ranked #85.

Bill Few Associates first reported a position in LRCX in Q4 2023 and has held it in 10 quarters since. 3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Bill Few Associates held 2,579 shares of Lam Research worth $1.12M as of Q2 2026.
  • Bill Few Associates sold 247 Lam Research shares in Q2 2026, an estimated $75K.
  • Lam Research made up 0.24% of Bill Few Associates's portfolio in Q2 2026, its #85 holding.
  • Bill Few Associates first reported a position in Lam Research in Q4 2023 and has held it in 10 quarters since.
  • 3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Bill Few Associates's 13F filing for Q2 2026, filed 7 Jul 2026.